Introduction
Cdk10 (previously referred to as PISSLRE) is a member of the Cdc2 family of kinases and has been implicated in the regulation of the G2/M phase of the cell cycle (Li et al., 1995) . Cdk10 was originally identi®ed based on its homology to Cdc2 and bears the hallmarks common to cyclin dependent kinases (Cdks) (Brambilla and Draetta, 1994; Grana et al., 1994) . These include XI conserved regions of protein kinases and a PSTAIRE-like sequence, PISSLRE. Cdk10 also contains amino acids that are important regulatory sites in Cdc2 and other Cdks. These include tyrosine and threonine sites in the ATP binding domain and a conserved threonine corresponding to threonine 161 of Cdc2. The phosphorylation status of these sites is critical for determining the activity of Cdks Morgan, 1997) , suggesting that Cdk10 is under similar regulation.
In addition to being regulated by phosphorylation of key residues, Cdk activity is also regulated by binding to important associating proteins. Cdks remain inactive unless associated with their cyclin partner. Overexpression of kinase inactive Cdks (also referred to as dominant negative mutants) functionally inactivate their wild type counterpart in a cell by competing for essential interacting proteins, in particular the cyclin partner (Herskowitz, 1987) . These mutant kinases contain a point mutation at a critical aspartate in the ATPase domain, thereby rendering the kinase enzymatically inactive, but maintaining proper structural conformation and, therefore, able to bind their normal protein partners. This leads to functional inactivation of the endogenous wild type Cdk and may halt cell cycle progression in the temporal location where the particular Cdk functions. For example, overexpression of dominant negative Cdc2 arrests cells in G2/M whereas dominant negative Cdk2 arrests cells in the G1 phase of the cell cycle and these blocks are rescued by co-expression of appropriate cyclins (van den Heuvel and Harlow, 1993 ).
Cdk10's protein associations are also likely to be important for its function in the cell. Overexpression of kinase inactive Cdk10 arrests cells in the G2/M phase of the cell cycle and leads to growth suppression in U20S cells (Li et al., 1995) similar to what has been observed for other Cdks involved in the cell cycle. However, a cyclin partner has yet to be identi®ed for this Cdk and no additional proteins have been characterized as binding to Cdk10. Identifying Cdk10 associating proteins is, therefore, of great interest as they may prove to regulate or be regulated by Cdk10. We conducted an interaction trap, or two-hybrid screen, in S. cerevisiae to identify Cdk10 associating proteins to aid our understanding of this putative kinase. In this study we report that Cdk10 binds the Ets2 transcription factor in vitro and in vivo. This interaction occurs through the N-terminus of Ets2, which contains Ets2's transactivation domain and the highly conserved Pointed (PNT) domain. The PNT domain has been implicated in protein ± protein interactions and we ®nd that Cdk10 requires an intact PNT domain to bind Ets2. However Cdk10 does not recognize the highly similar amino terminus of Ets1. In addition to interacting in vitro and in vivo, we ®nd that Cdk10 inhibits Ets2 transactivation in mammalian cells.
Results

Cdk10 interacts with the N-terminus of Ets2 in a yeast interaction trap
To help us understand the function of Cdk10, we wished to identify proteins that associate with this putative kinase. Two dierent isoforms of Cdk10, referred to by their GenBank entries as X78342 and L33264, have been identi®ed and they dier at both the carboxy and amino termini (Brambilla and Draetta, 1994; Grana et al., 1994) . However the majority of the amino acid sequence is predicted to be identical for the two isoforms.
An interaction trap, a speci®c variant of a twohybrid screen, was performed with Cdk10 using the method described by Gyuris et al. (1993) . This system uses the lexA DNA binding domain fused to a protein of interest to screen a galactose inducible library fused to an activation domain. Interacting proteins are identi®ed by activation of lexA-LEU2 and lexA-lacZ reporters in the presence of galactose. We did not wish to restrict our screen to one speci®c isoform of Cdk10 and so used the region common to both isoforms, referred to as cCdk10 (Figure 1a ), as the`bait' in our screen. The bait also contained a dominant negative point mutation in the ATPase domain thereby abolishing kinase activity. The lexA-cCdk10dn fusion has low inherent ability to activate the lexA-LEU2 and lexA-lacZ reporters and so was considered acceptable for the screen. Yeast strain EGY48 co-transformed with the lexA-lacZ reporter and lexA-cCdk10dn was used to screen a HeLa cell cDNA library fused to the B42 acid-blob activation domain. Candidate Cdk10 interacting proteins were initially identi®ed by selecting for cell growth in the absence of leucine with galactose as the carbon source. Putative positive clones from these candidates were identi®ed by activation of the lacZ reporter and demonstrating galactose dependent activation of the LEU2 and lacZ reporters. Prey plasmids were isolated from these putative positives and retested directly with lexA-cCdk10dn in the twohybrid assay. From these screens 11 positive prey plasmids were identi®ed and found to represent ®ve distinct human genes. Sequence analysis of the isolated prey plasmids identi®ed the N-terminus of the human transcription factor, Ets2, as one of the Cdk10 interacting proteins. The N-terminus of Ets2, from aa 1 to 178, was identi®ed in three independent positive clones from this screen. Ets2 does not activate the LEU2 or lacZ reporters with several control lexA fusions (krev1 and Cdk9) indicating that the interaction between Ets2 and Cdk10 is speci®c (Table 1 and data not shown).
The interaction trap was originally conducted with a truncation of Cdk10 bearing a point mutation in its predicted ATPase domain. This point mutation is predicted to inactivate the kinase but not alter its three dimensional conformation (Li et al., 1995) . We ®nd that Ets2 interacts equally well with wild type and mutant full length Cdk10 (Table 1 and data not shown). Therefore, full length Cdk10 (corresponding to the X78342 isoform of Cdk10), as opposed to the truncated version, was used in subsequent analysis.
The Ets2 Pointed domain is required for Cdk10 binding
The N-terminus of Ets2 contains a region from aa 69 to 168 referred to as the Pointed (PNT) domain. The PNT domain is a highly conserved motif found in many of the Ets family members. While the precise function of this domain is unclear, it has been proposed to mediate protein ± protein interactions (Graves and Petersen, 1998) .
We analysed the role of the PNT domain in Ets2's binding to Cdk10. To address whether the PNT domain is required for Ets2 binding of Cdk10, we used quantitative assays to measure lacZ expression in a two-hybrid assay. We truncated the PNT domain of Ets2 and compared it to the intact PNT domain in a quantitative two-hybrid assay with Cdk10. DPNT Ets2 contains the N-terminus of Ets2 from aa 1 to 129 fused to the activation domain in pYESTrp resulting in a partial deletion of the Ets2 PNT domain. N-term Ets2 corresponds to the same region of Ets2 in pYESTrp Oncogene Cdk10 interacts with Ets2 M Kasten and A Giordano but with the complete PNT domain (aa 1 to 178). We ®nd that truncation of the Ets2 PNT domain is sucient to abolish b-galactosidase activity in a twohybrid assay with Cdk10 wild type or dominant negative (Table 2) demonstrating that an intact PNT domain is essential for Ets2 to bind Cdk10. The Ets1 protein also has a PNT domain in its amino terminal region and is similar to Ets2 across the entire amino acid sequence. Therefore we examined whether the N-terminus of Ets1 also interacts with Cdk10 in a two-hybrid assay. N-term Ets1 (aa 1 to 148), containing the entire Ets1 PNT domain, only weakly activates the lacZ reporter in a two-hybrid assay with Cdk10 (Table 2) indicating that these two proteins do not strongly interact in yeast. This data suggests that there are either sequences within the PNT domain which provide binding speci®city or that additional sequences in Ets2 are important for mediating the association with Cdk10. It also demonstrates that Cdk10 does not bind to PNT domains indiscriminately in a two-hybrid assay.
Cdk10 interacts in vitro with full length Ets2
We repeatedly identi®ed the N-terminus of Ets2 in our two-hybrid screen; none of the Ets2 clones isolated contained full length Ets2. We wished to determine if Cdk10 could interact with the full length Ets2 protein.
However we found that full length human Ets2 is toxic when expressed in yeast strains EGY48 and W303 (data not shown). Therefore we assessed the ability of Cdk10 to interact with full length Ets2 in vitro. GSTCdk10 wild type and dominant negative were expressed and puri®ed from bacteria. GST alone, GST-Cdk2, and GST-Cdk4 were expressed and puri®ed for use as negative controls. Full length Ets2 was translated and radiolabeled in vitro and incubated with the various GST proteins. Full length Ets2 binds both wild type and dominant negative GST-Cdk10, but not with GST alone or with the other GST-Cdks examined ( Figure  2 ). This data supports that there is a direct interaction between Cdk10 and Ets2 and that Cdk10 can recognize the full length Ets2 protein. It further demonstrates binding speci®city between these two proteins.
Cdk10 and Ets2 interact in mammalian cells
Although we have shown that Cdk10 and Ets2 interact in live yeast cells, we wished to determine whether Cdk10 and Ets2 interact in mammalian cells. To address this question we co-expressed either wild type or dominant negative Cdk10 fused to the HA epitope with full length Ets2 fused to the X-press epitope in 293 cells. We chose to utilize tagged versions of Cdk10 because at present we do not have an antibody that reliably detects endogenous protein. The HA-Cdk10 protein was immunoprecipitated from whole cell extracts using an antibody recognizing the HA epitope, and the complexes were subjected to Western blot analysis. Cells expressing HA-Cdk10wt or X-press-Ets2 alone were used as negative controls. We ®nd that Ets2 is present in the Cdk10 complex when both proteins are co-expressed (Figure 3 ) demonstrating that these two proteins can interact in mammalian cells. Although the Ets2 signal is stronger in the dominant negative Cdk10 IP compared with the wild type Cdk10 IP, this dierence is likely due to enhanced expression of Cdk10 and Ets2 in these dominant negative transfections (note the level of expression in the cell extract lanes; Figure 3) . In summary, we ®nd that full length Ets2 can interact with both wild type and dominant negative Cdk10 in mammalian cells. S-labeled full length Ets2 protein. GST alone or fused to Cdc2 or Cdk2 were used as negative controls. After multiple washes to eliminate non-speci®c binding, beads were resuspended in denaturing sample buer and separated on a 10% SDS polyacrylamide gel. 100% of the labeled Ets2 protein used in the experiments was loaded onto the gel (Input). The gel was dried and exposed to X-ray ®lm Figure 3 Ets2 and Cdk10 associate in mammalian cells. 293 cells were transiently co-transfected with HA-Cdk10wt, HA-Cdk10dn, or the empty pcDNA3 vector and X-press-Ets2 and subjected to immunoprecipitation with anti-HA antibody. The immunocomplexes were analysed by 10% SDS ± PAGE followed by immunoblotting with anti-X-press antibody (upper panel) and anti-HA antibody (lower panel). The whole cell extracts (WCE) served to control for expression
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Overexpression of Cdk10 modulates Ets2 transactivation
The N-terminal region of Ets2 functions as a transcriptional activation domain (Chumakov et al., 1993; Schneikert et al., 1992) . Since Cdk10 binds to the N-terminus of Ets2, we wished to determine if Cdk10 could aect Ets2 transactivation. The construct Gal1-293 contains the N-terminus of Ets2 fused to the Gal4 DNA binding domain and strongly activates transcription of a mammalian reporter gene under the control of Gal4 binding sites (Chumakov et al., 1993) . We used this system to examine the eect of Cdk10 on Ets2 transcriptional activation. The Ets2 fusion, Gal1-293, was co-transfected into 293 cells with Cdk10 and the Gal4-luciferase reporter plasmid. Luciferase assays were performed on cell extracts to analyse activation by the Gal4-Ets2 fusion in the presence of Cdk10. We ®nd that co-expression of Cdk10 reduces transcription activation by Gal1-293 (Figure 4 ). Co-expression of Cdc2, however, does not signi®cantly aect Ets2 activation. The wild type and kinase inactive Cdk10 mutant inhibit Ets2 activation to similar degrees (Figure 4) indicating that down regulation of Ets2 transactivation is independent of Cdk10's kinase activity. In addition, Cdk10's eect on Ets2 transactivation appears speci®c, as Cdk10 overexpression did not down regulate the strong transcriptional activator, Gal4-VP16 (Figure 4) . This data provides further support that Cdk10 and Ets2 interact in vivo and that Cdk10 binding can in¯uence Ets2's transactivation activity.
Discussion
In this study we demonstrate that Cdk10 associates with the N-terminus of the Ets2 protein. Ets2 is a member of the Ets family of transcription factors characterized by a highly conserved DNA binding domain termed the ETS domain. Ets proteins are important regulators of gene expression during proliferation, dierentiation, and development. Outside of the ETS domain, located in the carboxy terminus of Ets2, many of the family members share limited homology, however Ets2 shares signi®cant similarity with the Ets1 protein in the amino terminus as well.
The amino terminus of Ets2 contains the highly conserved PNT domain. This domain is found in a signi®cant fraction of the known Ets proteins and is proposed to function in protein ± protein interactions (Graves and Petersen, 1998). The PNT domain of the Ets family member, TEL mediates self-association (Carroll et al., 1996; Jousset et al., 1997) , however other Ets family members examined do not appear to homodimerize (Jousset et al., 1997) . The PNT domain of these Ets proteins may serve to form heterodimers with other Ets proteins and/or other regulatory proteins. Indeed, fragments of Ets2 containing the PNT domain associate with a second Ets protein, ERG (Basuyaux et al., 1997) . Our data indicates that the PNT domain of Ets2 is also capable of recognizing non-Ets proteins in addition to other Ets family members.
The secondary structure of the murine Ets1 PNT domain has been determined by NMR (Slupsky et al., 1998 ). Ets1's PNT domain forms a monomeric ®ve alpha-helix bundle. Based on N-terminal amino acid sequence similarity between Ets1 and Ets2, our truncation, which removes 39 aa of the PNT domain, is predicted to contain the ®rst two alpha helices but missing helix three, four and ®ve. Deleting these three helices is expected to disrupt the tertiary structure and, therefore, activities associated with the PNT domain. Deletion of this region is sucient to abolish Ets2's interaction with Cdk10 demonstrating that Ets2 requires an intact PNT domain in order to interact with Cdk10.
We also ®nd that Cdk10 does not recognize the PNT domain of Ets1 in a two-hybrid assay even though Ets1 and Ets2 share signi®cant homology across their amino termini (Watson et al., 1988) . Our results indicate that, despite their high degree of similarity, there are either sequences within the PNT domain that provide binding speci®city or that additional Ets2 sequences are crucial for mediating the association with Cdk10.
The amino terminus of Ets2 corresponds to the Ets2 transactivation domain (Chumakov et al., 1993; Schneikert et al., 1992) and is required for transformation by Ets2 (Chumakov et al., 1993) . Although Ets2 is a phosphoprotein and phosphorylation of threonine 72 enhances Ets2's ability to activate transcription (Yang et al., 1996) , we have not observed phosphorylation of Ets2 by Cdk10 in vitro (data not shown). However, we do ®nd that ectopic expression of Cdk10 signi®cantly reduces transactivation by a Gal4-Ets2 chimera in mammalian cells. This data provides additional support that Cdk10 and Ets2 interact in vivo and that this interaction aects Ets2's function. Since the inhibition does not depend upon Cdk10's kinase activity, Cdk10 may be interfering with Ets2's association with the basal transcription machinery or other co-factors. Indeed, the amino terminus of Ets2 also interacts with the transcriptional coactivators, p300/CBP (Jayaraman et al., 1999) .
Interestingly, Ets2 has been found to be a regulator of Cdc2 expression and so appears to play a role in controlling the cell cycle (Wen et al., 1995) . Cdc2 is critical for the proper regulation of the G2/M transition in mammalian cells. Since Cdk10 is also thought to in¯uence this particular phase of the cell cycle, it is interesting to speculate that perhaps one of the ways that Cdk10 aects the cell cycle is by modulating Ets2 transcriptional activity and thereby aecting the level of Cdc2. However this is probably not the only mechanism by which Cdk10 aects cell cycle progression since Cdk10 inhibition of Ets2 transactivation is independent of its kinase activity, while inactive Cdk10 leads to a G2/M arrest in mammalian cells but wild type Cdk10 only shows a modest eect (Li et al., 1995) .
Future experiments may determine the degree to which Cdk10's association with Ets2 contributes to its cell cycle role and whether Cdk10 can aect Ets2's oncogenic potential. As inappropriate Ets2 expression can lead to cellular transformation of NIH3T3 cells (Seth et al., 1989) , and cervical and prostate cancers have been observed to have elevated levels of Ets2 (Liu et al., 1997; Simpson et al., 1997) , it is possible that modulation of Ets2 levels or activity may aect cancer cells. Indeed, overexpression of the Ets2 DNA binding domain inhibits colony formation in two prostate cancer cell lines (Sementchenko et al., 1998) . However, due to the similarity of Ets binding sites it is likely that overexpression of the Ets2 DNA binding domain inhibits the transcriptional activity of other Ets proteins as well. Cdk10's speci®city for Ets2, therefore, may prove valuable in speci®cally targeting Ets2 from among the vast family of Ets proteins.
Materials and methods
Plasmids
LexA fusions for the two-hybrid screen and assays were created by amplifying the desired region of Cdk10 from primers designed to create an in frame fusion with the LexA DNA binding domain of pMW101 (Watson et al., 1996) . All Cdk10 numbering is relative to the X78342 isoform (Brambilla and Draetta, 1994) . The Cdk10 dominant negative point mutation changes the aspartic acid at position 181 to an asparagine and has been previously described (Li et al., 1995) . LexA-cCdk10dn (MK40) contains amino acid (aa) 30 to 328 of Cdk10 with the dominant negative point mutation; lexA-Cdk10wt (MK135) contains the full length wild type Cdk10 construct; lexA-Cdk10dn (MK136) contains the full length Cdk10 with the dominant negative point mutation. LexA-krev1 was a generous gift from Erica Golemis. Fusions to the activation domain were also created by amplifying the desired region of the human Ets gene from primers designed to create an in frame fusion with the activation domain (AD) present in pYESTrp (Invitrogen). AD-N-term Ets2 (MK213) contains aa 1 to 178 of Ets2; AD-DPNT Ets2 (MK214) contains aa 1 to 129 of Ets2; AD-N-term Ets1 contains aa 1 to 148 of Ets1. GST fusions were created by fusing full length Cdk10 to the glutathione-S-transferase of pGEX 4T-2 (Pharmacia). GST-Cdk10wt (MK107) contains wild type Cdk10 and GST-Cdk10dn (MK132) contains dominant negative Cdk10. Cdk10 mammalian expression constructs were created by fusing the hemaglutinin (HA) epitope to the carboxy terminus of full length Cdk10 in pcDNA3 (Invitrogen). HA-Cdk10wt (MK112) contains wild type Cdk10; HACdk10dn (MK137) contains dominant negative Cdk10. Xpress-Ets2 (MK159) was created by fusing full length Ets2 to the X-press epitope present in the pcDNA3.1/HIS C vector (Invitrogen). The Gal4-luciferase reporter is as described (Puri et al., 2000) . The wild type and dominant negative Cdc2 mammalian expression constructs are as described (van den Heuvel and Harlow, 1993) . Gal1-293, Gal4 vector, and Gal4-VP16 are as described (Chumakov et al., 1993) .
Yeast two-hybrid screen
The two-hybrid screen, or interaction trap, was conducted essentially as described by Golemis et al. (1997) . Vectors encoding alternative antibiotic resistance other than ampicillin were used for the lexA fusion and the lexA-lacZ reporter (Watson et al., 1996) to facilitate subsequent isolation of the library plasmids. Screening was performed using lexA-cdk10dn, a truncation of the Cdk10 gene bearing a point mutation in the ATPase domain. This region corresponds to the region of Cdk10 that is common between the two described isoforms of Cdk10, X78342 and L33264. Expression of this and other baits was con®rmed by Western blot. Yeast strain EGY48 containing plasmids lexAcCdk10dn and the lexA-LacZ reporter, pMW106 (Watson et al., 1996) , was transformed with a HeLa cDNA library fused to the B42 activation domain (Golemis et al., 1997) . Transformants containing all three plasmids were selected on synthetic complete medium (Sherman, 1991) containing 2% glucose, supplemented with adenine and amino acids as appropriate but lacking essential components to select for plasmids. Approximately 8.4610 6 independent transformants were scraped from plates and pooled. Pooled cells were replated onto synthetic complete medium containing 2% galactose and 1% ranose selecting for plasmids and expression of the LEU2 reporter. Approximately 6610 7 cells were screened for leu+ growth in the presence of galactose.
Blue/white assays for yeast colony color were performed using the chromogenic substrate X-Gal on Whatman ®lters (Dohrmann et al., 1996) . Extracts were prepared and quantitative assays for b-galactosidase activity were performed on three independent transformants using the chromogenic reagent ONPG as described (Breeden and Nasmyth, 1987) . Standard deviations were less than 20%. Fold activation refers to the level of activation relative to the bait plus the empty activation domain vector, pYESTrp.
Cell culture and transient transfections
Two hundred and ninety-three cells (obtained from ATCC) were grown in DMEM supplemented with 10% FBS, Lglutamine, and antibiotics. Cells were transfected using the
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M Kasten and A Giordano standard calcium phosphate precipitation method . Ten micrograms each HA tagged Cdk10 (HACdk10wt and HA-Cdk10dn) and X-press tagged Ets2 (Xpress-Ets2) were transfected into 293 cells for use in immunoprecipitations. Where only one plasmid was transfected the total quantity of DNA transfected (20 mg) was maintained by the addition of the empty vector, pcDNA3.
In vitro translation and in vitro binding GST fusion proteins were expressed and puri®ed from BL21 bacteria as previously described (MacLachlan et al., 1998) . The X-press-Ets2 protein was in vitro translated using the TNT rabbit reticulocyte lysate kit (Promega) with [
35 S]-methionine. Two microliters of the labeled samples was incubated with 5 mg of GST proteins for 2 h at 48C. The samples were washed four times with 1 ml NENT (20 mM Tris, pH 8.0; 100 mM NaCl; 1 mM EDTA; 0.5% NP-40) supplemented with fresh protease inhibitors and 1 mM DTT. Bound proteins were eluted with 20 ml of 26 SDS-loading buer, resolved on a 10% polyacrylamide gel, and analysed by autoradiography.
Immunoprecipitations and immunoblot
Two hundred and ninety-three cells were collected 48 h after calcium phosphate transfection and extracts were prepared in Lysis Buer (50 mM Tris/Cl, pH 7.4; 5 mM EDTA; 250 mM NaCl; 50 mM NaF; 0.1 mM Na 3 VO 4 ; 0.1% Triton X-100; and protease inhibitors). Protein concentration was determined by Bradford assay (Bio-Rad) following the manufacturer instructions. Immunoprecipitations were performed with anti-HA polyclonal antibody (Santa Cruz) overnight at 48C and subsequently incubated with protein A-Sepharose (Pierce) for 2 h while rocking. The beads were washed four times with 1 ml Lysis Buer. Recovered proteins were analysed by immunoblot.
Immunocomplexes were separated on polyacrylamide gels and transferred to nitrocellulose membranes in Transfer Buer (25 mM Tris base; 192 mM glycine; 20% methanol) for immunoblots. Membranes were blocked in 5% nonfat milk in TBS-T (2 mM Tris/Cl, pH 7.6; 13.7 mM NaCl, and 0.1% Tween 20). Antibodies used in the immunoblots were incubated in 5% milk/TBS-T. The polyclonal anti-HA antibody was purchased from Santa Cruz and the anti-Xpress monoclonal antibody was purchased from Invitrogen. Both the anti-mouse and anti-rabbit secondary antibodies were conjugated to horseradish peroxidase (Amersham) and were visualized with an ECL detection system (NEN Life Sciences).
Luciferase assays
For luciferase assays subcon¯uent cell cultures were transfected by the calcium phosphate method using 0.5 mg of the Gal4-luciferase reporter, 1 mg of the Gal1-293 Ets2 eector (generously provided by Alexi Chumakov), and 4 mg of the indicated Cdk or vector construct. Luciferase assays were performed using a kit according to the manufacturer's instructions (Promega). Luciferase activities were normalized for transfection eciency by including 0.3 mg of b-gal expression plasmid (Promega) in the transfections and determining b-galactosidase levels by a standard quantitative liquid ONPG assay. Brie¯y, 50 ml of cell extract was mixed with 250 ml of b-gal Buer (60 mM Na 2 HPO 4 , 40 mM NaH 2 PO 4 , 10 mM KCl, 1 mM MgCl 2 , 50 mM b-mercaptoethanol) and 50 ml of ONPG solution (2 mg/ml ONPG in 60 mM Na 2 HPO 4 and 40 mM NaH 2 PO 4 ) and incubated at 378C. Reactions were stopped by the addition of 150 ml of 1 M sodium carbonate and absorbency was measured at A420. Luciferase assays were performed in duplicate and were repeated at least four times.
